科研论文
1.Feng Yu, Bangxing Hong, Xiao-Tong Song. A T-cell Engager-armed Oncolytic Vaccinia Virus to Target the Tumor Stroma Cancer Transl Med 2017;3(4):122–32.

Kota Iwahori, SunithaKakarla, Paulina Velasquez, Feng Yu, Zongzhen Yi, Claudia Gerken, Xiao-Tong Song, Stephen Gottschalk. Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells. MolTher. 23(1):171-8, 2015.    
2.Feng Yu, Xingbing Wang, Z Sheng Guo, David L Bartlett, Stephen M Gottschalk, Xiao-Tong Song, T-cell engager-armed oncolyticvaccinia virus significantly enhances antitumor therapy, MolTher. 22(1): 102-11, 2014.
 Stephen M Gottschalk, Feng Yu, MinjunJi, SunithaKararla, Xiao-Tong Song. A vaccine that co-targets tumor cells and cancer associated fibroblasts induces bystander T cells with potent antitumor activity. PLoS One. 8(12): e82658, 2013.
3.Yu F, Hao X, Zhao H, Ge C, Yao M, Yang S, Li J. DLK1 contributes to cell growth by increasing IFI16 expression in hepatocellular carcinoma. Liver Int, 30 (5): 703-14, 2010.

专利申请

(1) Xiao-Tong Song, Stephen Gottschalk, Feng Yu. T- cell engager-armed oncolyticvaccinia virus cancer therapy. Inventor: Patent Number: 61772803 。

(2) 孙怀昌，于峰，李国才。用于防治奶牛乳房炎的基因药物 (专利号: CN02148545.3)。